RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Dipeptidyl peptidase-4 inhibitors may accelerate cirrhosis decompensation in patients with diabetes and liver cirrhosis: a nationwide population-based cohort study in …

Dipeptidyl peptidase-4 inhibitors may accelerate cirrhosis decompensation in patients with diabetes and liver cirrhosis: a nationwide population-based cohort study in …

Add to Collection
Observational studies FS Yen, JCC Wei, HT Yip, CM Hwu, MC Hou… - Hepatology …, 2021 - Springer

Chapter : Section1
Journal Year : 2021
Cited by : 15.0

… Management of type 2 diabetes mellitus (T2DM) in patients … in patients with type 2 diabetes mellitus (T2DM) and cirrhosis. … We also excluded patients with type 2 diabetes or cirrhosis …..... Read More

Keywords : ["dipeptidyl inhibitor may accelerate cirrhosis decompensation", "nationwide populationbased cohort study", "liver cirrhosis", "patient", "diabetes"]
PubMed Link : https://link.springer.com/article/10.1007/s12072-020-10122-1
Google Scholar Link : https://scholar.google.com/scholar?cites=9389482986218196336&as_sdt=40005&sciodt=0,10&hl=en&num=20